Clara Bartra Selected Research

6-chlorotacrine

1/2022

Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Clara Bartra Research Topics

Disease

3	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2022
2	Neuroinflammatory Diseases 01/2023 - 01/2022
2	Cognitive Dysfunction 01/2023 - 12/2022
2	Dementia (Dementias) 01/2023 - 07/2021
1	Inflammation (Inflammations) 01/2024
1	Pain (Aches) 12/2021
1	Memory Disorders (Memory Loss) 07/2021
1	Stroke (Strokes) 07/2021

Drug/Important Bio-Agent (IBA)

4	Epoxide HydrolasesIBA 12/2022 - 07/2021
3	EnzymesIBA 12/2022 - 07/2021
2	C-Reactive ProteinIBA 01/2023 - 07/2021
1	AntioxidantsIBA 01/2024
1	ResveratrolIBA 01/2024
1	Streptozocin (Streptozotocin)FDA Link 01/2023
1	Protective AgentsIBA 01/2023
1	Cholinergic Agents (Cholinergics)IBA 01/2023
1	LipopolysaccharidesIBA 01/2023
1	Scopolamine (Hyoscine)FDA Link 01/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2022
1	AcetylcholinesteraseIBA 01/2022
1	6-chlorotacrineIBA 01/2022
1	AcidsIBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 07/2021
1	tau Proteins (tau Protein)IBA 07/2021

Therapy/Procedure

1	Oral Administration 01/2022
1	Therapeutics 12/2021